Medical Properties Trust Dirección

Dirección controles de criterios 2/4

El CEO de Medical Properties Trust es Ed Aldag , nombrado en Aug 2003, tiene una permanencia de 21.25 años. compensación anual total es $17.85M, compuesta por 5.6% salario y 94.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.8% de las acciones de la empresa, por valor de €20.55M. La antigüedad media del equipo directivo y de la junta directiva es de 7.8 años y 8.3 años, respectivamente.

Información clave

Ed Aldag

Chief Executive Officer (CEO)

US$17.9m

Compensación total

Porcentaje del salario del CEO	5.6%
Permanencia del CEO	21.3yrs
Participación del CEO	0.8%
Permanencia media de la dirección	7.8yrs
Promedio de permanencia en la Junta Directiva	8.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Ed Aldag en comparación con los beneficios de Medical Properties Trust?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	-US$3b
Jun 30 2024	n/a	n/a	-US$2b
Mar 31 2024	n/a	n/a	-US$1b
Dec 31 2023	US$18m	US$1m	-US$558m
Sep 30 2023	n/a	n/a	-US$35m
Jun 30 2023	n/a	n/a	US$70m
Mar 31 2023	n/a	n/a	US$302m
Dec 31 2022	US$16m	US$1m	US$901m
Sep 30 2022	n/a	n/a	US$1b
Jun 30 2022	n/a	n/a	US$1b
Mar 31 2022	n/a	n/a	US$1b
Dec 31 2021	US$17m	US$1m	US$654m
Sep 30 2021	n/a	n/a	US$558m
Jun 30 2021	n/a	n/a	US$517m
Mar 31 2021	n/a	n/a	US$512m
Dec 31 2020	US$17m	US$1m	US$429m
Sep 30 2020	n/a	n/a	US$449m
Jun 30 2020	n/a	n/a	US$408m
Mar 31 2020	n/a	n/a	US$378m
Dec 31 2019	US$17m	US$1m	US$372m
Sep 30 2019	n/a	n/a	US$319m
Jun 30 2019	n/a	n/a	US$966m
Mar 31 2019	n/a	n/a	US$998m
Dec 31 2018	US$13m	US$1m	US$1b
Sep 30 2018	n/a	n/a	US$1b
Jun 30 2018	n/a	n/a	US$349m
Mar 31 2018	n/a	n/a	US$311m
Dec 31 2017	US$8m	US$950k	US$288m

Compensación vs. Mercado: La compensación total de Ed($USD17.85M) está por encima de la media de empresas de tamaño similar en el mercado BG ($USD1.89M).

Compensación vs. Ingresos: La compensación de Ed ha aumentado mientras la empresa no es rentable.

CEO

Ed Aldag (60 yo)

21.3yrs

Permanencia

US$17,854,051

Compensación

Mr. Edward K. Aldag, Jr., also known as Ed, is a Founder of Medical Properties Trust, Inc. and has been its President and Chief Executive Officer since August 2003. He is President, Chief Executive Officer...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Edward Aldag	Founder	21.3yrs	US$17.85m	0.80% € 20.5m
R. Hamner	Founder	21.2yrs	US$9.11m	0.45% € 11.5m
Rosa Hooper	Senior VP of Operations & Secretary	no data	US$2.60m	0.060% € 1.5m
James Hanna	Senior VP	8.8yrs	US$3.04m	0.063% € 1.6m
Larry Portal	Senior VP & Senior Advisor to the CEO	1.7yrs	US$3.49m	0.069% € 1.8m
Tim Berryman	Managing Director of Investor Relations	no data	sin datos	sin datos
Andrew Babin	Senior Managing Director of Corporate Communications	4.4yrs	sin datos	sin datos
R. Savage	VP & Head of Global Acquisitions	no data	sin datos	sin datos
Charles Lambert	VP, Treasurer & MD of Capital Markets	6.8yrs	sin datos	0.044% € 1.1m

7.8yrs

Permanencia media

57.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de M3P es experimentado (7.8 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Edward Aldag	Founder	20.7yrs	US$17.85m	0.80% € 20.5m
R. Hamner	Founder	19.8yrs	US$9.11m	0.45% € 11.5m
C. Thompson	Independent Director	8.3yrs	US$268.16k	0.0091% € 233.6k
G. Dawson	Independent Director	20.6yrs	US$273.16k	0.026% € 656.5k
Michael Stewart	Independent Lead Director	8.3yrs	US$288.16k	0.037% € 946.1k
D. Sparks	Independent Director	10.2yrs	US$238.16k	0.016% € 412.1k
Elizabeth Pitman	Independent Director	6.8yrs	US$298.16k	0.013% € 328.1k
Emily Murphy	Independent Director	2.8yrs	US$238.16k	0.0086% € 221.1k
Caterina Mozingo	Independent Director	4.8yrs	US$268.16k	0.0094% € 240.8k

8.3yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: La junta directiva de M3P se considera experimentada (8.3 años de antigüedad promedio).

Medical Properties Trust Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Insufficient new directors

Medical Properties Trust, Inc., Annual General Meeting, May 30, 2024

Medical Properties Trust, Inc., Annual General Meeting, May 30, 2024

Insufficient new directors

Insufficient new directors

Insufficient new directors

Recent updates

Medical Properties Trust, Inc. Declares Regular Quarterly Cash Dividend on Common Stock, Payable on January 9, 2025

Medical Properties Trust, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Medical Properties Trust, Inc. Declares Regular Quarterly Cash Dividend on Common Stock, Payable on October 10, 2024

Medical Properties Trust, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Medical Properties Trust, Inc. Declares Regular Quarterly Cash Dividend, Payable on July 9, 2024

Medical Properties Trust Comments on Delayed Form 10-Q Filing and Related Notice from NYSE

Medical Properties Trust, Inc. announced delayed 10-Q filing

First quarter 2024 earnings released: US$1.23 loss per share (vs US$0.054 profit in 1Q 2023)

Insufficient new directors

Medical Properties Trust, Inc. to Report Q1, 2024 Results on May 09, 2024

Medical Properties Trust, Inc. Declares Regular Quarterly Dividend, Payable on May 1, 2024

Prime Healthcare Services, Inc. acquired Five Medical facilities in California and New Jersey from Medical Properties Trust, Inc. (NYSE:MPW) for $350 million.

Medical Properties Trust, Inc., Annual General Meeting, May 30, 2024

Medical Properties Trust, Inc., Annual General Meeting, May 30, 2024

Medical Properties Trust, Inc. to Report Q4, 2023 Results on Feb 21, 2024

Insufficient new directors

Third quarter 2023 earnings released: FFO per share: US$0.4 (vs US$0.42 in 3Q 2022)

Levi & Korsinsky, LLP Notifies Medical Properties Trust, Inc. Investors of A Class Action Lawsuit

Insufficient new directors

Medical Properties Trust, Inc. Investors Have Opportunity to Lead Medical Properties Trust, Inc. Securities Fraud Lawsuit

Third quarter 2023 earnings released: EPS: US$0.20 (vs US$0.37 in 3Q 2022)

Medical Properties Trust, Inc. Reports Unaudited Impairment Charges Results for the Third Quarter Ended September 30, 2023

Medical Properties Trust, Inc. Provides Unaudited Earnings Guidance for the Year 2023

Insufficient new directors

Medical Properties Trust, Inc. to Report Q3, 2023 Results on Oct 26, 2023

HMC Capital Limited (ASX:HMC) and HealthCo Healthcare and Wellness REIT (ASX:HCW) completed the acquisition of Healthscope Portfolio from Medical Properties Trust, Inc. (NYSE:MPW).

Pomerantz Law Firm Announces the Filing of Class Action Against Medical Properties Trust, Inc. and Certain Officers

Insufficient new directors

Medical Properties Trust, Inc. Declares Quarterly Cash Dividend, Payable on October 12, 2023

Medical Properties Trust, Inc. Provides Earnings Guidance for the Year 2023

Medical Properties Trust, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Insufficient new directors

The Gross Law Firm Files A Class Action Lawsuit Against Medical Properties Trust, Inc

Insufficient new directors

Insufficient new directors

Full year 2022 earnings released: EPS: US$1.51 (vs US$1.11 in FY 2021)

Medical Properties Trust, Inc., Annual General Meeting, May 25, 2023

LifePoint Health, Inc. completed the acquisition of an unknown majority stake in Springstone Health Opco, LLC from Medical Properties Trust, Inc. (NYSE:MPW) for approximately $210 million.

Medical Properties Trust, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad